JCR Pharmaceuticals Co., Ltd.
JCRRF
Price:
$3.145
Market Cap:
$57.21B
JCR Pharmaceuticals Co., Ltd., a specialized pharmaceutical company headquartered in Ashiya, Japan, and established in 1975, operates across the entire lifecycle of pharmaceutical products, regenerative medicines, and active drug substances. Its comprehensive activities in Japan encompass research, development, manufacturing, and both the import, export, and sale of these medical items. The company's current therapeutic offerings include several key treatments: GROWJECT, utilized for patients suffering from growth hormone deficiency and short stature. IZCARGO, specifically designed to address Mucopolysaccharidosis type II. Agalsidase Beta BS I.V. Infusion, administered for the management of ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2021-01-29
Stock Exchange
OTC
Ticker
JCRRF
PE Ratio
[28.59]
ROE
[4.64%]
Current Ratio
[1.16]
Dividend Yield
[4.26%]
Enterprise Value
[97.10B]
Dividend History
The Enterprise Value as of June 2026 (TTM) for JCR Pharmaceuticals Co., Ltd. (JCRRF) is 97.10B
According to JCR Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 97.10B. This represents a change of -8.75% compared to the average of 106.41B of the last 4 quarters.
JCR Pharmaceuticals Co., Ltd. (JCRRF) Historical Enterprise Value (quarterly & annually)
How has JCRRF Enterprise Value performed in the past?
The mean historical Enterprise Value of JCR Pharmaceuticals Co., Ltd. over the last ten years is 193.78B. The current 97.10B Enterprise Value has changed 4.91% with respect to the historical average. Over the past ten years (40 quarters), JCRRF's Enterprise Value was at its highest in in the June 2021 quarter at 456.18B. The Enterprise Value was at its lowest in in the March 2017 quarter at 77.32B.
Average
193.78B
Median
187.40B
Minimum
77.41B
Maximum
434.71B
JCR Pharmaceuticals Co., Ltd. (JCRRF) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of JCR Pharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.84%
Maximum Annual Enterprise Value = 434.71B
Minimum Annual Increase = -40.90%
Minimum Annual Enterprise Value = 77.41B
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 109.15B | 28.38% |
| 2025 | 85.02B | -22.35% |
| 2024 | 109.50B | -40.90% |
| 2023 | 185.28B | -30.52% |
| 2022 | 266.67B | -38.66% |
| 2021 | 434.71B | 50.88% |
| 2020 | 288.12B | 49.71% |
| 2019 | 192.45B | 1.54% |
| 2018 | 189.52B | 144.84% |
| 2017 | 77.41B | -6.67% |
JCR Pharmaceuticals Co., Ltd. (JCRRF) Average Enterprise Value
How has JCRRF Enterprise Value performed in the past?
The current Enterprise Value of JCR Pharmaceuticals Co., Ltd. (JCRRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
101.22B
5-year avg
151.12B
10-year avg
193.78B
JCR Pharmaceuticals Co., Ltd. (JCRRF) Enterprise Value vs. Peers
How is JCRRF’s Enterprise Value compared to its peers?
JCR Pharmaceuticals Co., Ltd.’s Enterprise Value is greater than Glass House Brands Inc. (1.08B), greater than Allergy Therapeutics plc (394.82M), greater than GenSight Biologics S.A. (23.81M), greater than Verano Holdings Corp. (846.53M), greater than ManifestSeven Holdings Corporation (22.25M), greater than Boiron S.A. (433.08M), greater than Lattice Biologics Ltd. (3.09M), less than Nxera Pharma Co., Ltd. (134.40B), greater than Beijing Tong Ren Tang Chinese Medicine Company Limited (3.45B), greater than Avon Technologies Plc (761.91M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.08B | $1.03B | |
| 394.82M | $655.46M | |
| 23.81M | $30.99M | |
| 846.53M | $470.36M | |
| 22.25M | $1.71K | |
| 433.08M | $553.86M | |
| 3.09M | $16.55K | |
| 134.40B | $567.36M | |
| 3.45B | $542.78M | |
| 761.91M | $662.29M |
Build a custom stock screener for JCR Pharmaceuticals Co., Ltd. (JCRRF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JCR Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
JCR Pharmaceuticals Co., Ltd. (JCRRF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like JCR Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is JCR Pharmaceuticals Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for JCR Pharmaceuticals Co., Ltd. (JCRRF)?
What is the 3-year average Enterprise Value for JCR Pharmaceuticals Co., Ltd. (JCRRF)?
What is the 5-year average Enterprise Value for JCR Pharmaceuticals Co., Ltd. (JCRRF)?
How does the current Enterprise Value for JCR Pharmaceuticals Co., Ltd. (JCRRF) compare to its historical average?